Skip to main content

Tag: Drug Evaluaton

FDA Responds to AbleChild’s MedWatch PSA Request for Public Education

Recently, AbleChild requested that the FDA run their own PSA (Public Service Announcement) to educate the public on how to report Adverse Drug Reactions directly to the Agency.  The FDA’s response to our request is shocking, as they state that because MedWatch is a “voluntary” program, there is no need to run the PSA to educate the people on its existence and importance.

Continue reading